Initiating insulin as part of the Treating To Target in Type 2 Diabetes (4-T) trial: an interview study of patients' and health professionals' experiences - PubMed (original) (raw)

Randomized Controlled Trial

. 2010 Oct;33(10):2178-80.

doi: 10.2337/dc10-0494. Epub 2010 Jun 30.

Affiliations

Randomized Controlled Trial

Initiating insulin as part of the Treating To Target in Type 2 Diabetes (4-T) trial: an interview study of patients' and health professionals' experiences

Nicholas Jenkins et al. Diabetes Care. 2010 Oct.

Abstract

Objective: To explore patients' and health professionals' experiences of initiating insulin as part of the Treating To Target in Type 2 Diabetes (4-T) randomized controlled trial.

Research design and methods: Interviews were conducted with 45 trial participants and 21 health professionals and thematically analyzed.

Results: Patients were generally psychologically insulin receptive when approached to participate in the 4-T trial. Their receptiveness arose largely from their personal experiences observing intensifying prior treatments and deteriorating blood glucose control over time, which led them to engage with and accept the idea that their diabetes was progressive. Health professionals also fostered receptiveness by drawing on their clinical experience to manage patients' anxieties about initiating insulin.

Conclusions: Previous studies may have overemphasized the problem of psychological insulin resistance and overlooked factors and treatment experiences that may promote insulin receptiveness among type 2 patients.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Brod M, Kongsø JH, Lessard S, Christensen TL: Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res 2009; 18: 23– 32 - PubMed
    1. Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV: Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care 2005; 28: 2543– 2545 - PubMed
    1. Korytkowski M: When oral agents fail: practical barriers to starting insulin. Int J Obes Relat Metab Disord 2002; 26( Suppl. 3): S18– S24 - PubMed
    1. Peyrot M, Rubin RR, Lauritzen T, Skovlund SE, Snoek FJ, Matthews DR, Landgraf R, Kleinebreil L: International DAWN Advisory Panel Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care 2005; 28: 2673– 2679 - PubMed
    1. Cefalu WT, Mathieu C, Davidson J, Freemantle N, Gough S, Canovatchel W: Patients' perceptions of subcutaneous insulin in the OPTIMIZE study: a multicenter follow-up study. Diabetes Technol & Ther 2008; 10: 25– 38 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources